China Natl Chem Engineering Co Net Assets
China Natl Chem Engineering Co net assets. Based on the latest financial reports, China Natl Chem Engineering Co (601117) has net assets worth CN¥76.24 Billion CNY (≈ $11.16 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥250.71 Billion ≈ $36.69 Billion USD) and total liabilities (CN¥174.47 Billion ≈ $25.53 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore China Natl Chem Engineering Co (601117) equity growth momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥76.24 Billion |
| % of Total Assets | 30.41% |
| Annual Growth Rate | 19.05% |
| 5-Year Change | 43.23% |
| 10-Year Change | 157.58% |
| Growth Volatility | 43.58 |
Net Assets of China Natl Chem Engineering Co (2008–2025)
Net assets of China Natl Chem Engineering Co from 2008 to 2025. This chart illustrates how China Natl Chem Engineering Co's net assets have evolved over time, based on quarterly financial data. See China Natl Chem Engineering Co (601117) net asset quality to measure how much of total assets are equity-financed.
Annual Net Assets for China Natl Chem Engineering Co (2008–2025)
The table below shows the annual net assets of China Natl Chem Engineering Co from 2008 to 2025. For live market cap and overall valuation, see how much is China Natl Chem Engineering Co worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥75.20 Billion ≈ $11.00 Billion |
+9.14% |
| 2024-12-31 | CN¥68.90 Billion ≈ $10.08 Billion |
+7.53% |
| 2023-12-31 | CN¥64.07 Billion ≈ $9.38 Billion |
+9.85% |
| 2022-12-31 | CN¥58.33 Billion ≈ $8.53 Billion |
+11.09% |
| 2021-12-31 | CN¥52.50 Billion ≈ $7.68 Billion |
+28.92% |
| 2020-12-31 | CN¥40.72 Billion ≈ $5.96 Billion |
+8.33% |
| 2019-12-31 | CN¥37.59 Billion ≈ $5.50 Billion |
+7.35% |
| 2018-12-31 | CN¥35.02 Billion ≈ $5.12 Billion |
+14.60% |
| 2017-12-31 | CN¥30.56 Billion ≈ $4.47 Billion |
+4.67% |
| 2016-12-31 | CN¥29.19 Billion ≈ $4.27 Billion |
+4.79% |
| 2015-12-31 | CN¥27.86 Billion ≈ $4.08 Billion |
+10.23% |
| 2014-12-31 | CN¥25.27 Billion ≈ $3.70 Billion |
+12.08% |
| 2013-12-31 | CN¥22.55 Billion ≈ $3.30 Billion |
+17.49% |
| 2012-12-31 | CN¥19.19 Billion ≈ $2.81 Billion |
+22.01% |
| 2011-12-31 | CN¥15.73 Billion ≈ $2.30 Billion |
+17.22% |
| 2010-12-31 | CN¥13.42 Billion ≈ $1.96 Billion |
+16.90% |
| 2009-12-31 | CN¥11.48 Billion ≈ $1.68 Billion |
+195.98% |
| 2008-12-31 | CN¥3.88 Billion ≈ $567.61 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to China Natl Chem Engineering Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 20539.1% over the analyzed period, indicating profitable operations and earnings retention.
China Natl Chem Engineering Co Net Assets Breakdown (December 2025)
China Natl Chem Engineering Co net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥42.34 Billion | 63.01% |
| Common Stock | CN¥6.11 Billion | 9.09% |
| Other Comprehensive Income | CN¥3.82 Billion | 5.68% |
| Other Components | CN¥14.93 Billion | 22.22% |
| Total Equity | CN¥67.19 Billion | 100.00% |
China Natl Chem Engineering Co Competitors by Market Cap
The table below lists competitors of China Natl Chem Engineering Co ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Telekom Austria AG
VI:TKA
|
$6.36 Billion |
|
Adani Total Gas Limited
NSE:ATGL
|
$6.36 Billion |
|
COVIVIO UNS.ADR/1/4
F:F5D0
|
$6.36 Billion |
|
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
|
$6.36 Billion |
|
Jiangsu Financial Leasing Co Ltd Class A
SHG:600901
|
$6.35 Billion |
|
Healthcare Realty Trust Incorporated
NYSE:HR
|
$6.34 Billion |
|
Avolta AG
SW:AVOL
|
$6.33 Billion |
|
Mycronic publ AB
ST:MYCR
|
$6.33 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in China Natl Chem Engineering Co's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 62,275,576,000 to 67,190,862,000, a change of 4,915,286,000 (7.9%).
- Net income of 6,436,146,000 contributed positively to equity growth.
- Dividend payments of 1,749,065,220 reduced retained earnings.
- Share repurchases of 38,976,127 reduced equity.
- Other comprehensive income increased equity by 300,946,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥6.44 Billion | +9.58% |
| Dividends Paid | CN¥1.75 Billion | -2.6% |
| Share Repurchases | CN¥38.98 Million | -0.06% |
| Other Comprehensive Income | CN¥300.95 Million | +0.45% |
| Other Changes | CN¥-33.76 Million | -0.05% |
| Total Change | CN¥- | 7.89% |
Book Value vs Market Value Analysis
This analysis compares China Natl Chem Engineering Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.64x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 7.42x to 0.64x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | CN¥0.96 | CN¥7.11 | x |
| 2009-12-31 | CN¥2.97 | CN¥7.11 | x |
| 2010-12-31 | CN¥2.63 | CN¥7.11 | x |
| 2011-12-31 | CN¥3.07 | CN¥7.11 | x |
| 2012-12-31 | CN¥3.67 | CN¥7.11 | x |
| 2013-12-31 | CN¥4.27 | CN¥7.11 | x |
| 2014-12-31 | CN¥4.78 | CN¥7.11 | x |
| 2015-12-31 | CN¥5.34 | CN¥7.11 | x |
| 2016-12-31 | CN¥5.59 | CN¥7.11 | x |
| 2017-12-31 | CN¥5.82 | CN¥7.11 | x |
| 2018-12-31 | CN¥6.63 | CN¥7.11 | x |
| 2019-12-31 | CN¥7.12 | CN¥7.11 | x |
| 2020-12-31 | CN¥7.63 | CN¥7.11 | x |
| 2021-12-31 | CN¥9.05 | CN¥7.11 | x |
| 2022-12-31 | CN¥8.66 | CN¥7.11 | x |
| 2023-12-31 | CN¥9.41 | CN¥7.11 | x |
| 2024-12-31 | CN¥10.18 | CN¥7.11 | x |
| 2025-12-31 | CN¥11.07 | CN¥7.11 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently China Natl Chem Engineering Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.58%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.39%
- • Asset Turnover: 0.77x
- • Equity Multiplier: 3.68x
- Recent ROE (9.58%) is below the historical average (10.91%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 17.73% | 2.79% | 0.93x | 6.83x | CN¥276.57 Million |
| 2009 | 8.76% | 3.49% | 0.89x | 2.83x | CN¥-138.14 Million |
| 2010 | 12.74% | 5.09% | 0.95x | 2.63x | CN¥356.83 Million |
| 2011 | 15.60% | 5.46% | 0.95x | 3.00x | CN¥853.11 Million |
| 2012 | 17.14% | 5.70% | 0.92x | 3.28x | CN¥1.28 Billion |
| 2013 | 15.94% | 5.44% | 0.86x | 3.39x | CN¥1.25 Billion |
| 2014 | 13.39% | 4.57% | 0.85x | 3.44x | CN¥801.23 Million |
| 2015 | 10.87% | 4.47% | 0.78x | 3.13x | CN¥227.78 Million |
| 2016 | 6.44% | 3.34% | 0.63x | 3.05x | CN¥-976.71 Million |
| 2017 | 5.49% | 2.66% | 0.67x | 3.09x | CN¥-1.28 Billion |
| 2018 | 5.88% | 2.37% | 0.84x | 2.95x | CN¥-1.35 Billion |
| 2019 | 8.71% | 2.95% | 0.89x | 3.30x | CN¥-452.83 Million |
| 2020 | 9.72% | 3.34% | 0.80x | 3.61x | CN¥-107.25 Million |
| 2021 | 9.61% | 3.37% | 0.77x | 3.69x | CN¥-186.50 Million |
| 2022 | 10.24% | 3.43% | 0.81x | 3.68x | CN¥126.25 Million |
| 2023 | 9.44% | 3.04% | 0.81x | 3.81x | CN¥-323.39 Million |
| 2024 | 9.13% | 3.06% | 0.80x | 3.75x | CN¥-539.62 Million |
| 2025 | 9.58% | 3.39% | 0.77x | 3.68x | CN¥-282.94 Million |
Industry Comparison
This section compares China Natl Chem Engineering Co's net assets metrics with peer companies in the Engineering & Construction industry.
Industry Context
- Industry: Engineering & Construction
- Average net assets among peers: $1,344,303,993
- Average return on equity (ROE) among peers: 5.44%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| China Natl Chem Engineering Co (601117) | CN¥76.24 Billion | 17.73% | 2.29x | $6.35 Billion |
| Shenzhen Ecobeauty Co Ltd (000010) | $165.66 Million | 1.06% | 0.78x | $193.46 Million |
| Shenzhen Sed Industry Co Ltd (000032) | $823.36 Million | 10.59% | 1.23x | $1.84 Billion |
| NORINCO International Cooperation Ltd (000065) | $428.71 Million | -10.83% | 2.13x | $1.59 Billion |
| Shenzhen Tagen Group Co Ltd (000090) | $1.04 Billion | 8.97% | 1.99x | $850.36 Million |
| Shandong Hi-Speed Road&Bridge (000498) | $2.31 Billion | 11.33% | 3.08x | $1.42 Billion |
| Jinyuan Cement Co Ltd (000546) | $4.26 Billion | 8.79% | 0.98x | $418.76 Million |
| Hunan Investment Group Co Ltd (000548) | $1.23 Billion | 5.55% | 0.33x | $309.74 Million |
| ChengDu Hi-Tech Development Co Ltd (000628) | $137.88 Million | 4.37% | 21.41x | $1.95 Billion |
| Gansu Engineering Consulting Group Co Ltd (000779) | $501.14 Million | 5.55% | 0.23x | $509.46 Million |
| Hainan Expressway Co Ltd (000886) | $2.55 Billion | 9.00% | 0.77x | $562.87 Million |
About China Natl Chem Engineering Co
China National Chemical Engineering Co., Ltd. engages in the chemical engineering business in China. It is involved in the contracting of construction engineering, petrochemicals, coal chemical industry, fine chemicals, pharmaceuticals, electric power, environmental ecological protection, infrastructure engineering and overseas engineering; and engineering consulting, surveying, design, construct… Read more